Phenomex Inc (CELL) Gross Profit Margin starting from the second quarter 2023 to second quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Phenomex Inc   (NASDAQ: CELL)


Phenomex Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



CELL Gross Profit Margin (Jun 30 2023)
Q2
(Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
(Jun 30 2022)
Q2
Y / Y Revenue Change -26.67 %
Seq. Revenue Change -24.16 %
Revenue In Millions $14.04
Gross Profit Margin 43.03 %
Gross Profit Margin Total Ranking # 2149
Gross Profit In Millions $6.04
Y / Y Gross Profit Change -53.25 %
Seq. Gross Profit Change -55 %


Commenting Second Quarter 2023 Gross Profit Margin
Phenomex Inc experienced contraction in Gross Profit by -55 % to $14 millions and Revenue by -24.16 %, while Gross Profit Margin fell to 43.03 % a new company low.


Observing second quarter 2023 results within Laboratory Analytical Instruments industry 20 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 982 to 2149.
Learn about Gross Margin
CELL's Gross Profit Margin second quarter 2023 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 21
Healthcare Sector # 382
Overall # 2119

Gross Profit Margin Statistics
High Average Low
81.37 % 68.84 % 43.03 %
(Jun 30 2019)   (Jun 30 2023)




Other Gross Profit Margin Profitability Ratios
CELL's Cumulative Gross Profit Margin
Laboratory Analytical Instruments Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CELL's Gross Profit Margin Profitability versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CELL's Competitors
Gross Profit Margin Profit Margin for Phenomex Inc 's Suppliers
Gross Profit Margin Profit Margin for CELL's Customers

You may also want to know
CELL's Annual Growth Rates CELL's Profitability Ratios CELL's Asset Turnover Ratio CELL's Dividend Growth
CELL's Roe CELL's Valuation Ratios CELL's Financial Strength Ratios CELL's Gross Profit Growth
CELL's Roa CELL's Inventory Turnover Ratio CELL's Growth Rates CELL's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2023, within Laboratory Analytical Instruments Industry Gross Profit MarginJun 30 2023 MRQ Gross ProfitJun 30 2023 MRQ Revenue
Talis Biomedical Corporation  98.80 %$ 0.574  Millions$ 0.581  Millions
Eyepoint Inc   80.32 %$ 7.313  Millions$ 9.105  Millions
Telesis Bio Inc   74.00 %$ 5.693  Millions$ 7.693  Millions
Seer Inc   69.52 %$ 2.281  Millions$ 3.281  Millions
10x Genomics Inc   67.94 %$ 99.612  Millions$ 146.612  Millions
Quanterix Corporation  63.50 %$ 19.138  Millions$ 30.138  Millions
Illumina Inc   62.24 %$ 732.000  Millions$ 1,176.000  Millions
Mettler toledo International Inc   59.42 %$ 583.543  Millions$ 982.117  Millions
Harvard Bioscience Inc   58.15 %$ 16.673  Millions$ 28.673  Millions
Cytek Biosciences Inc   57.28 %$ 28.162  Millions$ 49.162  Millions
Revvity Inc  56.74 %$ 402.331  Millions$ 709.066  Millions
Bio rad Laboratories Inc   53.27 %$ 362.483  Millions$ 680.483  Millions
Akoya Biosciences Inc   52.41 %$ 12.116  Millions$ 23.116  Millions
Bruker Corporation  49.96 %$ 340.500  Millions$ 681.500  Millions
Pressure Biosciences Inc   49.86 %$ 0.255  Millions$ 0.512  Millions
Standard Biotools Inc   49.28 %$ 13.602  Millions$ 27.602  Millions
Reflect Scientific Inc  48.67 %$ 0.061  Millions$ 0.124  Millions
Lifeloc Technologies Inc   45.71 %$ 1.042  Millions$ 2.280  Millions
Scientific Industries Inc   45.26 %$ 1.350  Millions$ 2.983  Millions
Astrotech Corp  43.72 %$ 0.181  Millions$ 0.414  Millions
Phenomex Inc   43.03 %$ 6.043  Millions$ 14.043  Millions
Agilent Technologies inc   39.35 %$ 658.000  Millions$ 1,672.000  Millions
Precipio inc   38.81 %$ 1.371  Millions$ 3.533  Millions
Avantor Inc   33.83 %$ 590.000  Millions$ 1,743.900  Millions
Pacific Biosciences Of California Inc   32.70 %$ 15.546  Millions$ 47.546  Millions
Thermogenesis Holdings Inc   31.93 %$ 0.469  Millions$ 1.469  Millions
Accelerate Diagnostics Inc   28.55 %$ 0.799  Millions$ 2.799  Millions
Bionano Genomics Inc   26.65 %$ 2.308  Millions$ 8.662  Millions
Kewaunee Scientific Corporation  24.36 %$ 11.914  Millions$ 48.914  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.